◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
OncoTherapy Science,Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
+Revenue 750.0M 610.1M 1.1B 1.2B 332.5M
Revenue Growth % 22.9% -46.2% -1.6% 247.0% --
+Operating Income -797.9M -1.1B -1.1B -2.1B -1.6B
Operating Margin % -106.4% -183.7% -97.5% -177.9% -492.6%
Non Operating Income 2.2M 26,000 576,000 1.0M 2.4M
Non Operating Expenses 19.4M 15.6M 27.3M 20.2M 3.7M
Ordinary Income -815.0M -1.1B -1.1B -2.1B -1.6B
Income Before Taxes -813.1M -1.3B -1.1B -2.6B -1.6B
Income Taxes 2.2M 2.4M 2.2M 1.2M 1.6M
+Net Income -815.3M -1.3B -1.1B -2.6B -1.6B
Net Margin % -108.7% -211.1% -98.6% -222.9% -469.7%
Eps -3.12 -6.05 -5.81 -13.72 -8.86
Depreciation Amortization -- -- -- 16.5M 49.0M
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Cash And Deposits 833.9M 527.7M 1.1B 1.8B 2.9B
Current Assets 1.1B 817.8M 1.4B 2.6B 3.2B
Property Plant Equipment -- -- -- 17,000 94.9M
Noncurrent Assets 49.5M 49.5M 89.2M 84.6M 174.0M
Total Assets 1.2B 867.3M 1.5B 2.7B 3.4B
Current Liabilities 327.7M 359.6M 609.2M 604.9M 194.9M
Total Liabilities 426.1M 513.6M 656.3M 705.0M 291.3M
Retained Earnings -26.9B -26.1B -24.8B -23.7B -21.1B
Total Equity 729.1M 353.7M 855.2M 2.0B 3.1B
Equity Ratio 0.57 0.32 0.52 0.71 0.89
Book Value Per Share 2.42 1.28 4.04 9.84 16.96
Num Employees 47.00 54.00 60.00 67.00 66.00
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Operating Cash Flow -815.0M -1.2B -794.9M -2.1B -1.8B
Investing Cash Flow -279,000 -33.4M -20.3M -467.9M -52.2M
Financing Cash Flow 1.1B 671.4M 96.0M 1.5B --
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...